Lantheus Holdings announces CEO succession plan; shares fall
23/01/2024 17:04
** Shares of medical diagnostics co Lantheus Holdings
LNTH.O fall ~6% to $51.59
** Co says current board chair Brian Markison will succeed
Mary Anne Heino as CEO from Mar. 1, 2024
** Heino will then assume the role of chair of the board of
directors
** Up to last close, stock was mostly flat in the last 12
months
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Recent news on Lantheus Holdings
See all newsStreet View: Lantheus' tumor kit setback seen as temporary, with growth catalysts still ahead
Brief: Lantheus Receives Complete Response Letter From FDA For Lnth-2501 (Ga 68 Edotreotide)
US FDA declines Lantheus’ tumor imaging kit over third-party manufacturing issues (updated)
US FDA declines to approve Lantheus’ tumor imaging kit
$7 billion could be a 'light' price tag for Lantheus, Truist analysts say